Work for Castle Biosciences, Inc.?

Claim Your Profile

Castle Biosciences, Inc. Logo Image

Castle Biosciences, Inc.

Castle Biosciences, Inc. Banner Image

Most Recent Annual Report

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

2019 Annual Report and Form 10K

Castle Biosciences, Inc.

Castle Biosciences, Inc. has reached its limit for free report views.

About Castle Biosciences, Inc.

51-200 Employees
Based in Friendswood, Texas

Castle Biosciences (Nasdaq: CSTL) is a commercial-stage dermatologic cancer company focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The Company currently offers tests for patients with cutaneous melanoma (DecisionDx®-Melanoma, DecisionDx®-CMSeq; www.SkinMelanoma.com), cutaneous squamous cell carcinoma (DecisionDx®-SCC, www.mySCCskincancer.com) and uveal melanoma (DecisionDx®-UM, DecisionDx®-PRAME and DecisionDx®-UMSeq; www.MyUvealMelanoma.com). Castle also has products in development for other underserved cancers, the most advanced of which is focused on patients who have a difficult-to-diagnose pigmented lesion. Castle Biosciences is based in Friendswood, Texas (Houston), and has laboratory operations in Phoenix, Arizona.

Ticker:
CSTL
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Diagnostic Substances (See More Diagnostic Substances Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol